Effect of lipid types on physicochemical characteristics, stability and antioxidant activity of gamma-oryzanol-loaded lipid nanoparticles

Journal of Microencapsulation

Volumn 26, Issue 7, 2009, Pages 614-626

  Ruktanonchai, Uracha ^a   Sakulkhu, Usawadee ^a   Bejrapha, Piyawan ^a   Opanasopit, Praneet ^b   Bunyapraphatsara, Nuntavan ^c   Junyaprasert, Varaporn ^c   Puttipipatkhachorn, Satit ^c  

^a NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

^b SILPAKORN UNIVERSITY   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Antioxidation activity; Gamma oryzanol; Nanoemulsion; Solid lipid nanoparticle; Stability

Indexed keywords

ACYLGLYCEROL; CETYL PALMITATE; DYNASAN 114; GAMMA ORYZANOL; LIPID; MIGLYOL; NANOPARTICLE; POLOXAMER; SOLID LIPID NANOPARTICLE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; WITEPSOLE E85;

ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG FORMULARY; DRUG RELEASE; DRUG STABILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; NANOEMULSION; PARTICLE SIZE; PHYSICAL CHEMISTRY; STORAGE TEMPERATURE;

ANTIOXIDANTS; CALORIMETRY, DIFFERENTIAL SCANNING; CELLS, CULTURED; HUMANS; LIPIDS; NANOPARTICLES; PARTICLE SIZE; PHENYLPROPIONATES;

EID: 70449394057     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652040802586571     Document Type: Article

References (44)

1. Akihisa T, Yashukawa K, Yamaura M, Ukiya M, Kimura Y, Shimizu N, et al. 2000. Triterpene alcohol and sterol ferulates from rice bran and their anti-inflammatory effects. J Agric Food Chem 48:2313-2319.
2. Alonso MJ. 2004. Nanomedicines for overcoming biological barriers. Biomed Pharmacother 58:168-172.
3. Bouchemal K, Briançon S, Pemer E, Fessi H. 2004. Nano-emulsion formulation using spontaneous emulsification: Solvent, oil and surfactant optimisation. Int J Pharm 280:241-251.
4. Bunjes H, Westesen K, Koch MHJ. 1996. Crystallization tendency and polymorphic transitions in triglyceride nanoparticles. Int J Pharm 129:159-173.
5. Cavalli R, Gasco MR, Chetoni P, Burgalassi S, Saettone MF. 2002. Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. Int J Pharm 238:241-245. (Pubitemid 34457892)
6. Cicero AF, Gaddi A. 2001. Rice bran oil and gamma-oryzanol in the treatment of hyperlipoproteinaemias and other conditions. Phytother Res 15:277-289.
7. Coppini D, Paganizzi P, Santi P, Ghirardini A. 2001. Capacità protettiva nei confronti delle radiazioni solari di derivati di origine vegetale. Cosmetic News 136:15-20.
8. Freitas C, Müller RH. 1999. Correlation between long-term stability of solid lipid nanoparticles (SLNTM) and crystallinity of the lipid phase. Eur J Pharm Sci 47:125-132.
9. Hiramitsu T, Armstrong D. 1991. Preventive effect of antioxidants on lipid peroxidation in the retina. Ophthal Res 23:196-203.
10. Jenning V, Gohla S. 2000. Comparison of wax and glyceride solid lipid nanoparticles (SLN-). Int J Pharm 196:219-222.
11. Jenning V, Thünhemann AF, Gohla SH. 2000. Characterisation of a Novel Solid lipid Nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm 199:167-177. (Pubitemid 30236188)
12. Jores K, Mehnert W, Drechsler M, Bunjes H, Johann C, Mäder K. 2004. Investigations on the structure of solid lipid nanoparticles (SLNs) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionationand transmission electron microscopy. J Contr Rel 95:217-227.
13. Juliano C, Cossu M, Alamanni MC, Piu L. 2005. Antioxidant activity of gamma-oryzanol: Mechanism of action and its effect on oxidative stability of pharmaceutical oils. Int J Pharm 299:146-154.
14. Kim SJ, Han D, Moon KD, Rhee JS. 1995. Measurement of superoxide dismutase-like activity of natural antioxidants. Biosci Biotechnol Biochem 59:822-826.
15. Lilitchan S, Tangprawat C, Aryusuk K, Krisnangkura S, Chokmoh S, Krisnangkura K. 2008. Partial extraction method for the rapid analysis of total lipids and--oryzanol contents in rice bran. Food Chem 106:752-759.
16. Lim SJ, Lee MK, Kim CK. 2004. Altered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticle powders. J Contr Rel 100:53-61.
17. Mühlen A, Schwarz C, Mehnert W. 1998. Solid lipid nanoparticles (SLN) for controlled drug delivery-drug release and release mechanism. Eur J Pharm Biopharm 45:149-155. (Pubitemid 28167741)
18. Müller RH, Lucks JS. 1996. Medication vehicles made of solid lipid particles (solid lipid nanospheres-SLN). Germany. European Patent 0605497.
19. Müller RH, Mäder K, Gohla S. 2000. Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of art. Eur J Pharm Biopharm 50:161-177.
20. Müller RH, Petersen RD, Hommoss A, Pardeike J. 2007. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliv Rev 59:522-530
21. Müller RH, Rühl D, Runge S, Schulze-Forster K, Mehnert W. 1997. Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant. Pharm Res 14:458-462. (Pubitemid 27205004)
22. Müller RH, Radtke M, Wissing SA. 2002a. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 54:S131-S155.
23. Müller RH, Radtke M, Wissing SA. 2002b. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 242:121-128.
24. Müller RH, Radtke M, Wissing SA. 2002c. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 54: 131-155.
25. Mehnert W, Mäder K. 2001. Solid lipid nanoparticles: Production, characterization and applications. Adv Drug. Deliv Rev 47:165-196.
26. Nanua JN, McGregor JU, Godber JS. 2000. Influence of high-oryzanol rice bran oil on the oxidative stability of whole milk powder. J Dairy Sci 83:2426-2431.
27. Nishiyama N, Kataoka K. 2006. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol Therapeut 112:630-648.
28. Rosen H, Abribat T. 2005. The rise and rise of drug delivery. Nature Rev Drug Discov 4:381-385.
29. Rukmini C, Raghuram TC. 1991. Nutritional and biochemical aspects of the hypolipidemic action of rice bran oil: A review. J Am Coll Nutrit 10:593-601.
30. Ruktanonchai U, Limpakdee S, Meejoo S, Sakulkhu U, Bunyapraphatsara N, Junyaprasert V, et al. 2008. The Effect of cetyl palmitate crystallinity on physical properties of gamma-oryzanol encapsulated in solid lipid nanoparticles. Nanotechnology 19:1-10.
31. Saupe A, Gordon KC, Rades T. 2006. Structural investigations on naoemulsions, solid lipid nanoparticles and naotstructured lipid carriers by cryo-field emission scanning electron microscopey and Raman spectroscopy. Int J Pharm 314:56-62.
32. Schöler N, Zimmermann E, Katzfey U, Hahn H, Müller RH, Liesenfeld O. 2000. Preserved solid lipid nanoparticles (SLN) at low concentrations do cause neither direct nor indirect cytotoxic effects in peritoneal macrophages. Int J Pharm 196:235-239.
33. Schubert MA, Harms M, Müller-Goymann CC. 2006. Structural investigations on lipid nanoparticles containing high amounts of lecithin. Eur J Pharm Sci 27:226-236.
34. Solans C, Izquierdo P, Nolla J, Azemar N, Garcia MJ. 2005. Nano-emulsions. Curr Opin Colloid Interface Sci 10:102-110.
35. Souto EB, Anselmi C, Centini M, Müller RH. 2005. Preparation and characterization of n-dodecyl-ferulate-loaded solid lipid nanoparticles (SLN-). Int J Pharm 295:261-268.
36. Teeranachaideekul V, Müller RH, Junyaprasert VB. 2007. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)-Effects of formulation parameters on physicochemical stability. Int J Pharm 340:198-206.
37. Teeranachaideekul V, Souto EB, Junyaprasert VB, Müller RH. 2007. Cetyl palmitate-based NLC for topical delivery of Coenzyme Q10-Development, physicochemical characterization and in vitro release studies. Eur J Pharm Biopharm 67:141-148.
38. Vivek K, Reddy H, Murthy RSR. 2007. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles. AAPS PharmSciTech 8:E1-E9.
39. Washington C. 1996. Stability of lipid emulsions for drug delivery. Adv Drug Deliv Rev 20:131-145.
40. Westesen K, Bunjes H, Koch MHJ. 1997. Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading and sustained release potential. J Contr Rel 48:223-236.
41. Wissing SA, Müller RH. 2002. Solid lipid nanoparticles as carrier for sunscreens: In vitro release and in vivo skin penetration. J Contr Rel 81:225-233.
42. Xu Z, Godber JS. 1999. Purification and identification of components of oryzanol in rice bran oil. J Agric Food Chem 47:2724-2728.
43. Xu Z, Hua N, Godber JS. 2001. Antioxidant activity of tocopherols, tocotrienols, and--oryzanol components from rice bran against cholesterol oxidation accelerated by 2,20-Azobis(2-methylpropionamidine) dihydrochloride. J Agric Food Chem 49:2077-2081.
44. Zhang N, Ping Q, Huang G, Xu W, Cheng Y, Han X. 2006. Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin. Int J Pharm 327:153-159.